about
Frailty in mouse ageing: A conceptual approachInvolvement of microRNA in microglia-mediated immune responseLiposomal and viral vectors for gene therapy of the central nervous system.MicroRNA-21 silencing enhances the cytotoxic effect of the antiangiogenic drug sunitinib in glioblastomaMicroRNA deregulation and chemotaxis and phagocytosis impairment in Alzheimer's disease.Cell-penetrating peptides as nucleic acid delivery systems: from biophysics to biological applications.MiRNA-21 silencing mediated by tumor-targeted nanoparticles combined with sunitinib: A new multimodal gene therapy approach for glioblastoma.MicroRNAs in glioblastoma: role in pathogenesis and opportunities for targeted therapies.Role of microRNAs in the regulation of innate immune cells under neuroinflammatory conditions.Cell-Penetrating Peptides-Mechanisms of Cellular Uptake and Generation of Delivery Systems.Early miR-155 upregulation contributes to neuroinflammation in Alzheimer's disease triple transgenic mouse model.Application of thermoresponsive PNIPAAM-b-PAMPTMA diblock copolymers in siRNA delivery.S4(13)-PV cell-penetrating peptide induces physical and morphological changes in membrane-mimetic lipid systems and cell membranes: implications for cell internalization.siRNA delivery by a transferrin-associated lipid-based vector: a non-viral strategy to mediate gene silencing.Tumor-targeted Chlorotoxin-coupled Nanoparticles for Nucleic Acid Delivery to Glioblastoma Cells: A Promising System for Glioblastoma Treatment.Tf-lipoplex-mediated c-Jun silencing improves neuronal survival following excitotoxic damage in vivo.Temperature-responsive cationic block copolymers as nanocarriers for gene delivery.S4(13)-PV cell penetrating peptide and cationic liposomes act synergistically to mediate intracellular delivery of plasmid DNA.Gemini surfactants mediate efficient mitochondrial gene delivery and expression.Tf-lipoplex-mediated NGF gene transfer to the CNS: neuronal protection and recovery in an excitotoxic model of brain injury.Tf-lipoplexes for neuronal siRNA delivery: a promising system to mediate gene silencing in the CNS.Targeted lipoplexes for siRNA delivery.CdTe quantum dots as fluorescent probes to study transferrin receptors in glioblastoma cells.Quantifying miRNA Deregulation in Alzheimer's Disease.Towards frailty biomarkers: Candidates from genes and pathways regulated in aging and age-related diseasesRoles of Microglial and Monocyte Chemokines and Their Receptors in Regulating Alzheimer's Disease-Associated Amyloid-β and Tau PathologiesEffects of a New Bioceramic Material on Human Apical Papilla CellsmiR-155 modulates microglia-mediated immune response by down-regulating SOCS-1 and promoting cytokine and nitric oxide productionAbnormal mGluR-mediated synaptic plasticity and autism-like behaviours in Gprasp2 mutant miceMultimodal highly fluorescent-magnetic nanoplatform to target transferrin receptors in cancer cells
P50
Q26738573-ECE737AD-1DA1-45A3-B319-9BBADEC93A9DQ26851399-F18F3919-0DC5-43E3-AE3E-8EFC33343D7DQ36230558-579118DD-F1B3-4E0F-BE11-45D76CEE91D6Q36580732-0B837B82-9501-46BD-8E60-825C14D1AF64Q36934159-BBF72749-10F1-4B27-A4F1-EFAD7597EEBBQ38058876-F92A5ABD-1FE5-4DF8-9901-91E7C0754A47Q38299859-B947F718-2965-4ABB-B9F1-292616E17FBBQ38329198-C667075B-A76A-4955-BEB9-0645A34538E6Q38593729-6005E7D5-9FF3-4087-B6E4-8202F976F970Q38974236-1C767186-A1CF-4153-BAAC-3EB89AC19937Q38978614-282AEB20-DAA7-4A1C-9F04-B5D3166E5358Q39034188-346FEBDB-16D6-4C84-9A9E-0DB604732EF6Q39666244-84020645-DC88-4BC6-A42B-054BEE248EB9Q40160552-B82B129D-A3A7-4828-8BFD-86EF670E8077Q41459815-0F2A3EE3-A02B-4734-9538-2F9DFF5EE086Q43242536-8C91D8D3-4ACE-4240-AD07-C35BE41D9E6EQ44387674-3DF04151-1E20-45A6-BC42-7DAB3AEB7619Q45421794-FF10A979-B650-433E-8C0A-80F8EA66D13FQ45872574-617040B8-921A-45B4-815D-9EB18E11E189Q45882612-7DA205DC-BE97-4ED1-8E4D-A83F54396877Q46363932-11A4157F-D134-4147-B342-03BF8F236D52Q50577617-F38CB649-E6E7-4F54-B60A-DF687D48AC2BQ51698212-3331D575-B311-479C-9775-866FBCC89E6AQ52670442-1783F191-7375-4921-A058-74792E1E1C96Q57314968-D4B08373-D32C-4D90-A8BF-1611A96D3FACQ58780923-4E213792-8A17-40E2-9825-531267B909D5Q60952865-04AD951A-0037-4F36-B407-7B2B86F8E436Q61083877-6381997D-B8A2-40DE-8639-8F4A2A328EACQ64104339-008BA998-C8F5-4BC4-9383-CE23B200A886Q91716599-F8E36958-3ECF-4084-B979-91A8FC81AF94
P50
description
onderzoeker
@nl
researcher ORCID: 0000-0001-5145-4561
@en
name
Ana L Cardoso
@es
Ana L Cardoso
@nl
Ana L Cardoso
@sl
Ana L. Cardoso
@en
type
label
Ana L Cardoso
@es
Ana L Cardoso
@nl
Ana L Cardoso
@sl
Ana L. Cardoso
@en
prefLabel
Ana L Cardoso
@es
Ana L Cardoso
@nl
Ana L Cardoso
@sl
Ana L. Cardoso
@en
P1053
M-4161-2013
P106
P1153
24402669300
P21
P31
P3829
P496
0000-0001-5145-4561